Wisconsin scientists are among those conducting dozens of clinical trials worldwide on the use of psilocybin to treat depression. They say the evidence shows that, in combination with therapy, it shows great promise. ...
Xanomeline and trospium chloride (Cobenfy) has no boxed warnings...
The FDA is intent on improving the enrollment of participants -- also known as "subjects" -- from underrepresented populations in clinical studies for drugs and devices....
The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the Neffy epinephrine nasal spray. Neffy is a non-needle-based epinephrine treatment for anaphylaxis and other allergic reactions...
The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older....
Today, the U.S. Food and Drug Administration issued a draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies,” to assist medical product sponsors in submitting Diversity Action Plans to support certain clinical studies....
An FDA advisory committee on Monday unanimously supported the investigational drug donanemab for treating early Alzheimer's disease....
The US Food and Drug Administration (FDA) plans to release a draft guidance this year on the use of artificial intelligence/machine learning (AI/ML) to support drug development....
Palo Alto, California-based biotechnology company Guardant Health has applied for US Food and Drug Administration approval of Shield, its blood test to screen for early signs of colorectal cancer, and on Thursday, a panel of expert advisers to the FDA gathered to discuss data on...
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer....
